{"transactions":[{"id":693091,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T20:01:38.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":18300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/6th of the shares subject to this option shall vest and become exercisable on each of the next six (6) monthly anniversaries of August 5, 2026, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting dates."}],"balance_after":18300,"derivative":{"exercise_price":9.16,"expiration_date":"2036-08-04","underlying":"Common Stock","underlying_shares":18300},"source":{"system":"sec-edgar","filing":"0001776004-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000177600426000003/ownership.xml","form_type":"4"}},{"id":729162,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T20:25:13.000Z","date":"2026-06-21","kind":"grant","planned":false,"acquired":true,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":4200,"derivative":{"exercise_price":8.1,"expiration_date":"2036-06-20","underlying":"Common Stock","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001776004-26-000001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000177600426000001/ownership.xml","form_type":"4"}},{"id":1111750,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:09:59.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":26400,"derivative":{"exercise_price":0.78,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0000950170-25-086166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017025086166/ownership.xml","form_type":"4"}},{"id":1111749,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:09:59.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":5900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was issued Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":108566,"source":{"system":"sec-edgar","filing":"0000950170-25-086166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017025086166/ownership.xml","form_type":"4"}},{"id":1427680,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-20T20:05:11.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":70200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares shall vest in thirty-six (36) equal monthly installments following August 19, 2024; provided, however, that all vesting shall cease if the Reporting Person resigns from the Issuer's Board of Directors or otherwise ceases to serve as a director of the Issuer."}],"balance_after":70200,"derivative":{"exercise_price":1.55,"expiration_date":"2034-08-18","underlying":"Common Stock","underlying_shares":70200},"source":{"system":"sec-edgar","filing":"0000950170-24-099073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024099073/ownership.xml","form_type":"4"}},{"id":2779430,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2021-03-19T00:48:37.000Z","date":"2020-10-23","kind":"tax_withholding","acquired":false,"shares":4957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person is disposing of 4,957 restricted stock units as a result of a revised tax rate for such restricted stock units"}],"balance_after":11931,"source":{"system":"sec-edgar","filing":"0000899243-21-012680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321012680/doc4.xml","form_type":"4"}},{"id":2779429,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2021-03-19T00:48:37.000Z","date":"2019-12-06","kind":"grant","acquired":false,"shares":16888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was issued Restricted Stock Units (\"RSU\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance"},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount of securities reported herein have been adjusted to reflect the 1-for-7 reverse stock split that was effected in September 2020 in connection with the merger of resTORbio, Inc. and Adicet Therapeutics, Inc., formerly known as Adicet Bio, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities reported herein have been adjusted to reflect the 1-for-7 reverse stock split that was effected in September 2020 in connection with the merger of resTORbio, Inc. and Adicet Therapeutics, Inc., formerly known as Adicet Bio, Inc."}],"balance_after":16888,"source":{"system":"sec-edgar","filing":"0000899243-21-012680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321012680/doc4.xml","form_type":"4"}},{"id":2855017,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T02:16:32.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":41100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the Vesting Commencement date, provided that the Reporting  Person remains in continuous service as of the applicable vesting dates."}],"balance_after":41100,"derivative":{"exercise_price":16.82,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":41100},"source":{"system":"sec-edgar","filing":"0000899243-21-007031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321007031/doc4.xml","form_type":"4"}},{"id":2906148,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-15T21:30:22.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the Vesting Commencement date, provided that the Reporting  Person remains in continuous service as of the applicable vesting dates."}],"balance_after":80000,"derivative":{"exercise_price":13.27,"expiration_date":"2031-01-12","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-21-002194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321002194/doc4.xml","form_type":"4"}},{"id":3028661,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-18T01:55:30.000Z","date":"2020-09-17","kind":"grant","acquired":true,"shares":193027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries."}],"balance_after":193027,"derivative":{"exercise_price":16.11,"expiration_date":"2030-09-16","underlying":"Common Stock","underlying_shares":193027},"source":{"system":"sec-edgar","filing":"0000899243-20-025652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924320025652/doc4.xml","form_type":"4"}},{"id":3349895,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-06T22:24:16.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":88667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares shall vest on December 6, 2020, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":88667,"derivative":{"exercise_price":1.27,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":88667},"source":{"system":"sec-edgar","filing":"0000899243-19-028705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319028705/doc4.xml","form_type":"4"}},{"id":3349894,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-12-06T22:24:16.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":118222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was issued Restricted Stock Units  (\"RSU\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":118222,"source":{"system":"sec-edgar","filing":"0000899243-19-028705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319028705/doc4.xml","form_type":"4"}},{"id":3526190,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25441,"kind":"person","name":"Klickstein Lloyd","position":1,"cik":"0001776004","reported_name":"Klickstein Lloyd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-15T20:21:35.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on May 13, 2020, and the remaining shares shall vest in 12 equal quarterly installments thereafter."}],"balance_after":295000,"derivative":{"exercise_price":8.08,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0000899243-19-013558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319013558/doc4.xml","form_type":"4"}}]}